Ketamine Dosing for Pain Management
For acute pain management, administer ketamine as a 0.5 mg/kg IV bolus followed by a continuous infusion of 1-2 μg/kg/min (or 0.06-0.12 mg/kg/hr), which reduces opioid requirements by approximately 22 mg morphine equivalents without increasing side effects. 1
Intravenous Dosing by Clinical Context
Perioperative Pain Management
- Intraoperative use: Administer 0.5 mg/kg as a loading dose after anesthesia induction, followed by continuous infusion at 0.125-0.25 mg/kg/hr (maximum 0.5 mg/kg/hr) 2
- Discontinue the infusion 30 minutes before the end of surgery and administer a longer-acting opioid to prevent an analgesic gap 1
- For pediatric patients, use 0.5 mg/kg as an adjunct to intraoperative opioids, with optional continuous infusion of 0.1-0.2 mg/kg/hr (maximum 0.4 mg/kg/hr) 3
Acute Pain in Emergency/ICU Settings
- Initial bolus: 1-4.5 mg/kg IV over 60 seconds for anesthesia induction; for analgesia alone, use lower doses of 0.1-0.35 mg/kg 4
- Continuous infusion: 0.5-2 mg/kg/hr (maximum 100 mg/hour) using the lowest effective dose 1
- Breakthrough pain in PACU: 0.5 mg/kg titrated to effect 3
- Low-dose ketamine at 0.3 mg/kg provides superior pain relief compared to 0.15 mg/kg when used as an adjunct to morphine, though it may cause more dysphoria and dizziness 5
Cancer-Related Neuropathic Pain
- Start with subanesthetic doses when other modalities fail, though evidence is limited 1
- For chronic neuropathic pain in advanced cancer, begin with 10 mg/day by continuous IV infusion, increasing by 10 mg/day every 4-6 hours to 50 mg/day, then by 25 mg/day every 12-24 hours until pain relief is achieved 6
- Gradual dose titration prevents psychotomimetic effects at doses below 300 mg/day without requiring prophylactic psychotropic medications 6
Oral Ketamine Dosing
Chronic Pain Management
- Starting dose: 0.5 mg/kg racemic ketamine (or 0.25 mg/kg S-ketamine) as a single oral dose 7
- Titration: Increase by the same amount if required, typically given 3-4 times daily for continuous analgesic effect 7
- Effective maintenance dose: Mean effective oral dose is approximately 2 mg/kg daily, divided into 3-4 doses 8
- When converting from parenteral to oral administration, maintain the same daily dosage initially, then adjust based on clinical effect 7
- The injection fluid can be taken orally 7
Route-Specific Considerations
Intramuscular Administration
- Dose range: 6.5-13 mg/kg IM 4
- A dose of 9-13 mg/kg produces surgical anesthesia within 3-4 minutes, lasting 12-25 minutes 4
Preparation and Dilution
- Do not inject the 100 mg/mL concentration IV without proper dilution 4
- Dilute with equal volume of Sterile Water, Normal Saline, or 5% Dextrose in Water 4
- For maintenance infusion, prepare 1 mg/mL solution by adding 10 mL of 50 mg/mL (or 5 mL of 100 mg/mL) to 500 mL of IV fluid 4
- Use immediately after dilution 4
Critical Safety Measures
Monitoring Requirements
- Continuous cardiac monitoring and pulse oximetry during ketamine infusion 1
- Regular assessment of sedation level, respiratory status, and hemodynamic parameters 1, 2
- Emergency airway equipment must be immediately available 4
- Practitioners must be able to identify and rescue patients from unintended deep sedation 2
Minimizing Adverse Effects
- Co-administer benzodiazepines to minimize psychotomimetic effects (dysphoria, nightmares, hallucinations), especially at higher doses and with prolonged use 1
- Administer an antisialagogue prior to induction to reduce salivation 4
- Administer slowly over 60 seconds when giving IV bolus; rapid administration causes respiratory depression and enhanced vasopressor response 4
Absolute Contraindications
- Uncontrolled cardiovascular disease 1, 2
- Pregnancy 1
- Active psychosis 2
- Severe liver dysfunction 2
- High intracranial or ocular pressure 2
Special Populations
Patients with Shock
- Ketamine maintains cardiovascular stability through NMDA blockade and preserved adrenal function, making it superior to propofol or dexmedetomidine 9
- Use reduced doses (start at lower end of 0.5 mg/kg IV bolus) with careful monitoring, as ketamine can suppress myocardial contractility when catecholamine reserves are depleted 9
Patients on Chronic Opioids
- Ketamine is more effective and causes fewer adverse effects in patients already receiving opioid therapy (7% failure rate vs. 36% in opioid-naive patients) 8
- Results in mean opioid sparing of 63% 8
Common Pitfalls to Avoid
- Do not continue ketamine postoperatively beyond the immediate perioperative period, as this increases hallucination risk without enhancing analgesia 2
- Do not use mixed agonist-antagonists (butorphanol, pentazocine) in combination with ketamine 3
- Monitor for genitourinary pain in patients with chronic ketamine use; consider cessation if symptoms develop 4
- Purposeless and tonic-clonic movements during ketamine anesthesia do not indicate inadequate anesthesia and do not require additional dosing 4